Tirzepatide was no longer considered in shortage, removing compounding privileges, until litigation remanded the decision.
Tirzepatide was no longer considered in shortage, removing compounding privileges, until litigation remanded the decision.
Healthes’ AVP of Information Security, Tony Brown, discusses how cyber threats affect workers’ comp organizations.
NCCI hosted a recent webinar on opioid utilization, while Fair Health published a new Opioid Tracker tool to monitor state opioid data.
WCRI reports for Delaware and Philadelphia reported increases, matching patterns seen previously in other states.
These assistants must be under the supervision of a board-authorized provider.
A new issue of RxInformer magazine, plus Leaders Speak posts in WorkCompWire, featuring Sandy Shtab and Silvia Sacalis.
The benefits of different screening strategies and therapeutic interventions.
The push comes after a letter carrier died after working without air conditioning in 95° weather.
The FDA requested additional trial data, with researchers eager to continue psychedelic trials.